Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 4, 2011 | CellNovo | $48.3M Series B | — | Advent Venture Partners, Auriga Partners, Credit Agricole Private Equity, Forbion, HealthCare Ventures, Nesta |
| Mar 30, 2010 | Reverse Medical | $14.0M Series B | — | BioStar Ventures, Early Stage Partners, Emergent Medical Partners, Getz Brothers, MedFocus Funds, South Australian Life Science Advancement Partnership, Wexford Capital |